Literature DB >> 16857191

Effects of commissural de- and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis.

David Liebetanz1, Doron Merkler.   

Abstract

Feeding of copper chelator cuprizone induces reversible demyelination, predominantly of the corpus callosum in C57/Bl6 mice. With the availability of knockout and transgenic mice, this animal model of multiple sclerosis has increasingly attracted scientists to study the roles of various factors involved in de- and remyelination. However, central motor deficits have not been reported in this model so far. In the present study, we introduce a novel murine motor test, the motor skill sequence (MOSS). This test is designed to detect latent deficits in motor performance. In a first step, we habituated mice to training wheels composed of regularly spaced crossbars till maximal wheel-running performance was achieved. Subsequently, the animals were exposed to wheels with irregularly spaced crossbars demanding high-level motor coordination. This two-step approach minimized a contribution of cardiopulmonary and musculoskeletal training to any improvement of motor performance on the complex wheels. We applied the MOSS test under acute cuprizone-induced demyelination as well as in remyelinated mice after cuprizone withdrawal. Demyelinated animals on a cuprizone diet already showed reduced running performance on the training wheels as compared to control animals. This was even more pronounced when these mice were subsequently exposed to the complex wheels. In contrast, remyelinated animals after cuprizone withdrawal did not exhibit any functional impairment on the training wheels. Latent motor skill deficits were however revealed on the complex wheels, although clearly ameliorated as compared to acutely demyelinated mice. Our results show that latent motor deficits of cuprizone-induced demyelination and after remyelination can be quantified by MOSS. This motor test thus expands the usability of the cuprizone model to a functional level and might also be applicable to other animal models of human CNS diseases associated with subtle motor deficits of central origin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16857191     DOI: 10.1016/j.expneurol.2006.05.032

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  56 in total

1.  The Effect of Melatonin on Behavioral, Molecular, and Histopathological Changes in Cuprizone Model of Demyelination.

Authors:  Gelareh Vakilzadeh; Fariba Khodagholi; Tahereh Ghadiri; Amir Ghaemi; Farshid Noorbakhsh; Mohammad Sharifzadeh; Ali Gorji
Journal:  Mol Neurobiol       Date:  2015-08-27       Impact factor: 5.590

2.  Phosphorylation of αB-crystallin supports reactive astrogliosis in demyelination.

Authors:  Hedwich F Kuipers; Jane Yoon; Jack van Horssen; May H Han; Paul L Bollyky; Theo D Palmer; Lawrence Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-14       Impact factor: 11.205

3.  Discoidin domain receptor 1, a tyrosine kinase receptor, is upregulated in an experimental model of remyelination and during oligodendrocyte differentiation in vitro.

Authors:  Neus Franco-Pons; Jordi Tomàs; Bárbara Roig; Carme Auladell; Lourdes Martorell; Elisabet Vilella
Journal:  J Mol Neurosci       Date:  2008-10-04       Impact factor: 3.444

Review 4.  Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.

Authors:  Jeffrey K Huang; Stephen P J Fancy; Chao Zhao; David H Rowitch; Charles Ffrench-Constant; Robin J M Franklin
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

5.  Retrospective Analysis of the Effects of Identification Procedures and Cage Changing by Using Data from Automated, Continuous Monitoring.

Authors:  Maria A Lim; Erwin B Defensor; Jordan A Mechanic; Puja P Shah; Evelyn A Jaime; Clifford R Roberts; David L Hutto; Laura R Schaevitz
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-02-14       Impact factor: 1.232

6.  Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.

Authors:  Gelareh Vakilzadeh; Fariba Khodagholi; Tahereh Ghadiri; Marzieh Darvishi; Amir Ghaemi; Farshid Noorbakhsh; Ali Gorji; Mohammad Sharifzadeh
Journal:  Mol Neurobiol       Date:  2014-08-17       Impact factor: 5.590

7.  Brain metabolite changes in subcortical regions after exposure to cuprizone for 6 weeks: potential implications for schizophrenia.

Authors:  Gen Yan; Yinghua Xuan; Zhuozhi Dai; Zhiwei Shen; Guishan Zhang; Haiyun Xu; Renhua Wu
Journal:  Neurochem Res       Date:  2014-10-28       Impact factor: 3.996

Review 8.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

9.  Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.

Authors:  Li-Jin Chew; Paolo Fusar-Poli; Thomas Schmitz
Journal:  Dev Neurosci       Date:  2013-02-27       Impact factor: 2.984

10.  Zebrafish myelination: a transparent model for remyelination?

Authors:  Clare E Buckley; Paul Goldsmith; Robin J M Franklin
Journal:  Dis Model Mech       Date:  2008 Nov-Dec       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.